Organika Health Products Inc. Bromelain Tablets
Organika Health Products Inc. Bromelain Tablets, NPN 80033203: natural health product licensed in Canada. Medicinal ingredients: Bromélaïne de tige.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bromélaïne de tige Source : Ananas comosus - Tige | 450 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus - Tige | 13,500,000 FCC PU | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Dioxyde de silicium colloïdal, Acide stéarique, Maltodextrine, Croscarmellose de sodium, Dihydrate dibasique de phosphate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Digestive enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents or antibiotics or before having surgery.
- Known Adverse Reactions
Hypersensitivity/allergy has been known to occur, in which case, discontinue use. Nausea, vomiting, and diarrhea have been known to occur, in which case, discontinue use (and consult a health care practitioner).
Product record
- Other names
- Organica R Professional Line Bromelain tablets
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80033203
- Status
- Active licence
- Licence date
- 28 June 2012
- Revision date
- 18 May 2016
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80033203
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Inc. Bromelain Tablets: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80033203-organika-health-products-inc-bromelain-tablets, updated 18 May 2016.